PSC Capital Partners - aVenture Asset Manager Research
Location
Minneapolis, MN, US
Founded
2003
PSC Capital Partners, a division of Piper Sandler, focuses on growth equity investments across various sectors. The firm typically invests in Series B to Series D rounds, with portfolio companies raising between $13.5 million to $50 million in total funding.
Notable portfolio companies include Akoya Biosciences, Elligo Health Research, Foodsby, Moxe Health, and Xenex. As part of Piper Sandler, a global financial services firm, PSC Capital Partners leverages extensive industry expertise and a broad network to provide strategic guidance and support to its portfolio companies, helping them accelerate growth and achieve their business objectives.
PSC Capital Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies6
Current Portfolio Count6
Top Investment Stages
Series B3 (50.0%)
Series D2 (33.3%)
Series C1 (16.7%)
Stage Mix
Series B 50%Series D 33%Series C 17%
Concentration shown as share of disclosed investments by stage.